» Articles » PMID: 1414218

Myasthenia Gravis in Hong Kong Chinese. 1. Epidemiology and Adult Disease

Overview
Specialty Neurology
Date 1992 Aug 1
PMID 1414218
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A territory-wide study of myasthenia gravis (MG) was conducted in Hong Kong. Two hundred and sixty-two Chinese patients (159 adult and 103 paediatric onset) were identified, corresponding to a point prevalence and period prevalence of 53.5 and 62.2 per million respectively, and an average annual incidence of 4.0 per million population. Nine patients died, 7 from MG, giving a case fatality rate of 0.027. Female predominance was present in the whole group of patients (female to male ratio 1.6:1) and in those with adult disease (ratio 2.1:1), but not in those with onset in childhood (ration 1.1:1). Onset of disease was most common in the first 3 decades of life, and became less common in subsequent decades. Juvenile onset MG occurred in 39.3% of patients and restricted ocular MG in 47.9%. Familial occurrence was found in 5 patients. In the 159 adult onset patients, ocular disease was most common (32.7%), followed by mild generalised (29.6%), moderately severe generalised (24.5%), fulminating (11.9%) and late severe disease (1.3%). The mean age of onset of symptoms was 36.7 years. The symptomatology was similar to that of Caucasoid populations. Autoimmune thyroid disease was the commonest associated disease, and the incidence of thymoma among thymic abnormalities was high at 38%.

Citing Articles

Clinical spectrum of myasthenia gravis: An institute experience over 8 years from North East India.

Synmon B, Rawat S, Kynta R, Hussain M, Sharma S, Lyngdoh B J Family Med Prim Care. 2023; 11(11):7158-7162.

PMID: 36993138 PMC: 10041265. DOI: 10.4103/jfmpc.jfmpc_617_22.


Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P J Transl Med. 2021; 19(1):516.

PMID: 34930325 PMC: 8686543. DOI: 10.1186/s12967-021-03185-7.


Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Green J, Barohn R, Bartoccion E, Benatar M, Blackmore D, Chaudhry V BMJ Open. 2020; 10(9):e037909.

PMID: 32948566 PMC: 7511637. DOI: 10.1136/bmjopen-2020-037909.


Gender differences in quality of life among patients with myasthenia gravis in China.

Dong D, Chong M, Wu Y, Kaminski H, Cutter G, Xu X Health Qual Life Outcomes. 2020; 18(1):296.

PMID: 32883289 PMC: 7470440. DOI: 10.1186/s12955-020-01549-z.


Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases.

Zhao J, Wang C, Xu X, Zhang Y, Ren H, Ren Z Front Neurol. 2019; 10:1142.

PMID: 31736858 PMC: 6834766. DOI: 10.3389/fneur.2019.01142.